Vasco Azevedo Selected Research

Lymphadenitis (Adenitis)

11/2019	A panel of recombinant proteins for the serodiagnosis of caseous lymphadenitis in goats and sheep.
3/2019	Establishment of an objective endpoint in mice model for caseous lymphadenitis vaccine trials.
12/2018	NMR insights on nano silver post-surgical treatment of superficial caseous lymphadenitis in small ruminants.
1/2018	Identification of membrane-associated proteins with pathogenic potential expressed by Corynebacterium pseudotuberculosis grown in animal serum.
1/2018	Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
9/2017	Quadruplex PCR assay for identification of Corynebacterium pseudotuberculosis differentiating biovar Ovis and Equi.
5/2017	Recombinant esterase from Corynebacterium pseudotuberculosis in DNA and subunit recombinant vaccines partially protects mice against challenge.
12/2014	Corynebacterium pseudotuberculosis cp09 mutant and cp40 recombinant protein partially protect mice against caseous lymphadenitis.
11/2014	Serological proteome analysis of Corynebacterium pseudotuberculosis isolated from different hosts reveals novel candidates for prophylactics to control caseous lymphadenitis.
12/2013	Association between haptoglobin and IgM levels and the clinical progression of caseous lymphadenitis in sheep.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vasco Azevedo Research Topics

Disease

31	Infections 03/2022 - 08/2002
15	Neoplasms (Cancer) 04/2022 - 02/2005
14	Lymphadenitis (Adenitis) 11/2019 - 03/2011
11	Inflammation (Inflammations) 01/2022 - 01/2008
10	Mucositis 01/2022 - 01/2017
10	Colitis 03/2020 - 01/2011
7	COVID-19 01/2022 - 01/2020
5	Tuberculosis (Tuberculoses) 01/2021 - 03/2012
4	Abscess 06/2022 - 12/2011
4	Weight Loss (Weight Reduction) 01/2021 - 11/2014
4	Mastitis 11/2019 - 01/2011
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2017 - 01/2011
4	Schistosomiasis (Bilharziasis) 01/2012 - 09/2004
3	Granuloma 06/2022 - 09/2004
3	Diarrhea 01/2021 - 12/2019
3	Disease Progression 01/2017 - 12/2013
3	Brucellosis (Malta Fever) 01/2013 - 02/2002
2	Bovine Mastitis 03/2022 - 01/2018
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Carcinogenesis 01/2021 - 01/2013
2	Abdominal Pain (Pain, Abdominal) 01/2021 - 01/2020
2	Heart Diseases (Heart Disease) 01/2021 - 08/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 09/2017
2	Wounds and Injuries (Trauma) 01/2019 - 12/2018
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2008
2	Breast Neoplasms (Breast Cancer) 01/2016 - 11/2014
2	Schistosomiasis mansoni 12/2008 - 09/2004
1	Bacterial Infections (Bacterial Infection) 04/2022
1	Oral Candidiasis (Thrush) 01/2022
1	Denture Stomatitis 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Whooping Cough (Pertussis) 06/2021
1	Leprosy (Hansen's Disease) 04/2021
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
24	VaccinesIBA 04/2022 - 02/2002
11	Pharmaceutical PreparationsIBA 04/2021 - 01/2011
8	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2012
8	AntigensIBA 01/2021 - 02/2002
7	CytokinesIBA 06/2022 - 01/2011
7	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 02/2017
6	Interleukin-10 (Interleukin 10)IBA 01/2017 - 01/2011
5	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2018
5	Dextrans (Dextran)FDA Link 03/2020 - 04/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 01/2018
4	Biological ProductsIBA 01/2022 - 03/2013
4	Virulence Factors (Pathogenicity Factors)IBA 03/2021 - 04/2011
4	AcidsIBA 01/2021 - 01/2014
4	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2013
4	DNA VaccinesIBA 01/2017 - 08/2006
3	SilverIBA 01/2022 - 12/2018
3	InterleukinsIBA 01/2022 - 08/2002
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2013
3	SodiumIBA 03/2020 - 01/2014
3	Recombinant ProteinsIBA 11/2019 - 12/2014
3	bacterial fibronectin-binding proteinsIBA 01/2017 - 08/2014
3	CatalaseIBA 01/2017 - 01/2008
3	EnzymesIBA 01/2017 - 05/2012
3	Interleukin-12 (IL 12)IBA 01/2014 - 08/2002
2	Bacteriocins (Lantibiotics)IBA 03/2022 - 01/2020
2	InflammasomesIBA 01/2022 - 01/2020
2	InterferonsIBA 01/2022 - 11/2020
2	PrebioticsIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 01/2021 - 01/2018
2	Cardiac GlycosidesIBA 01/2021 - 08/2020
2	ProteomeIBA 11/2020 - 11/2014
2	Antiviral Agents (Antivirals)IBA 11/2020 - 01/2020
2	Antimicrobial PeptidesIBA 01/2020 - 10/2018
2	Pancreatitis-Associated ProteinsIBA 10/2018 - 02/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2014
2	Superoxide DismutaseIBA 01/2017 - 02/2011
2	Complementary DNA (cDNA)IBA 06/2015 - 11/2014
2	IronIBA 03/2014 - 01/2011
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2014 - 04/2012
2	Immunoglobulin M (IgM)IBA 12/2013 - 12/2011
2	HaptoglobinsIBA 12/2013 - 12/2011
2	Combined VaccinesIBA 01/2012 - 01/2011
2	Interferon-gamma (Interferon, gamma)IBA 03/2011 - 08/2002
2	Trinitrobenzenesulfonic AcidIBA 02/2011 - 01/2011
2	A-Form DNA (A-DNA)IBA 11/2006 - 08/2002
2	Ribosomal Proteins (Ribosomal Protein)IBA 01/2003 - 02/2002
1	ChemokinesIBA 06/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Sulfalene (Longum)IBA 01/2022
1	Secretory Immunoglobulin A (SIgA)IBA 01/2022
1	AllergensIBA 01/2022
1	Viral AntigensIBA 01/2022
1	NaphthoquinonesIBA 04/2021
1	diospyrinIBA 04/2021
1	yersiniabactinIBA 03/2021
1	colibactinIBA 03/2021
1	Phospholipase DIBA 02/2021
1	Bacterial VaccinesIBA 02/2021

Therapy/Procedure

12	Therapeutics 04/2022 - 11/2014
10	Drug Therapy (Chemotherapy) 04/2022 - 09/2004
4	Oral Administration 01/2021 - 08/2005
1	Radiotherapy 04/2022